News & Insights

  • Clear

Four AGs Partner with FCC to Tackle Privacy and Data Protection Issues

The AGs of Connecticut, Illinois, New York, and Pennsylvania signed memoranda of understanding (MOUs) with the FCC to share expertise and resources to enforce federal and state privacy laws and regulations. The agreements will allow the FCC and state investigators to coordinate efforts when building cases against possible bad actors and otherwise taking enforcement action…

Read More

AGs Argue Jackson Hewitt Must be Held to Account for No-Poach Agreements

A coalition of 19 Democratic AGs, led by New Jersey AG Matthew Platkin, filed an amicus brief in the U.S. District Court for the District of New Jersey in support of former tax preparers for Jackson Hewitt, Inc., who allege they were harmed by no-poach agreements signed with the tax preparation chain. In the brief,…

Read More

Alleged Deceptive Conduct Sparks Illinois Suit Against Residents Energy

Illinois AG Kwame Raoul filed a lawsuit against Residents Energy, LLC, alleging that the alternative retail electric supplier violated the Illinois Consumer Fraud and Deceptive Business Practices Act, as well as the Illinois Telephone Solicitations Act, by using deceptive and unfair tactics to switch consumers from public utility companies to more expensive contracts with Residents…

Read More

AGs Tell Congress that EATS Act Ruins their Appetite

A group of 16 Democratic AGs wrote a letter to Congressional leaders opposing the passage of the Ending Agricultural Trade Suppression (EATS) Act, which restricts state and local governments abilities to set agricultural product standards and arose following the Supreme Court’s 2023 ruling in National Pork Producers Council v. Ross that upheld California regulation of…

Read More

Trouble on the Horizon for Amgen’s Planned Acquisition

Six Democratic AGs joined the FTC in filing a lawsuit to block Amgen Inc.’s planned purchase of Horizon Therapeutics PLC, alleging that the transaction raises antitrust concerns and violates the Clayton Act. According to the complaint, Horizon Therapeutics is currently the only company to manufacture medicines to treat certain rare autoimmune diseases—thyroid eye disease and…

Read More